Volume 42, Issue 18, Page 7 (15 October 2009)
9 of 55
PREVIEW
FULL TEXT
FULL-TEXT PDF (240 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
BERLIN — Men treated with endocrine therapy for prostate cancer are at increased risk of developing and dying from several types of cardiovascular disease, according to a large observational analysis of 30,642 Swedish patients.
PII: S1097-8690(09)70712-7
© 2009 Elsevier Inc. All rights reserved.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
PREVIEW